Loading…
Reported covered position: Internship with former Representative John Carney of Delaware.
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Priority for Pediatric Cures Act
Client: BRIDGEBIO PHARMA, INC. · Firm: BRIDGEBIO PHARMA, INC.
Orphan drug policies General issues and provisions related to PBM Reform General issues and provisions related to tariffs H.R.1532 and S.822 - Scientific EXPERT Act Priority for Pediatric Cures Act (H.R.10359)
Mikaela Naylon Give Kids a Chance Act
Client: BRIDGEBIO PHARMA, INC. · Firm: BRIDGEBIO PHARMA, INC.
H.R.7148 - Consolidated Appropriations Act, 2026 Give Kids a Chance Act of 2025 - H.R. 1262; S 932 Orphan drug policies General issues and provisions related to PBM Reform
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BRIDGEBIO PHARMA, INC. via BRIDGEBIO PHARMA, INC.
2026 · third_quarter · Q3
Orphan drug policies General issues and provisions related to PBM Reform General issues and provisions related to tariffs H.R.1532 and S.822 - Scientific EXPERT Act Priority for Pediatric Cures Act (H.R.10359)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIDGEBIO PHARMA, INC. via BRIDGEBIO PHARMA, INC.
2026 · second_quarter · Q2
Source: Senate LDA
Orphan drug policies General issues and provisions related to PBM Reform General issues and provisions related to tariffs H.R.1532 and S.822 - Scientific EXPERT Act
Orphan drug policies General issues and provisions related to PBM Reform General issues and provisions related to tariffs H.R.1532 and S.822 - Scientific EXPERT Act Priority for Pediatric Cures Act (H.R.10359)
Consolidated Appropriations Act, 2026
Client: BRIDGEBIO PHARMA, INC. · Firm: BRIDGEBIO PHARMA, INC.
H.R.7148 - Consolidated Appropriations Act, 2026 Give Kids a Chance Act of 2025 - H.R. 1262; S 932 Orphan drug policies General issues and provisions related to PBM Reform
Orphan drug policies General issues and provisions related to PBM Reform General issues and provisions related to tariffs H.R.1532 and S.822 - Scientific EXPERT Act
Orphan drug policies General issues and provisions related to PBM Reform General issues and provisions related to tariffs H.R.1532 and S.822 - Scientific EXPERT Act Priority for Pediatric Cures Act (H.R.10359)
H.R.7148 - Consolidated Appropriations Act, 2026 Give Kids a Chance Act of 2025 - H.R. 1262; S 932 Orphan drug policies General issues and provisions related to PBM Reform
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BRIDGEBIO PHARMA, INC. · Firm: BRIDGEBIO PHARMA, INC.
Give Kids a Chance Act of 2025 - H.R. 1262; S 932 General issues and provisions related to PBM Reform ORPHAN Cures Act - included in H.R. 1 - One Big Beautiful Bill Act Orphan drug policies
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BRIDGEBIO PHARMA, INC. · Firm: BRIDGEBIO PHARMA, INC.
Give Kids a Chance Act of 2025 - H.R. 1262; S 932 General issues and provisions related to PBM Reform ORPHAN Cures Act - included in H.R. 1 - One Big Beautiful Bill Act Orphan drug policies
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BRIDGEBIO PHARMA, INC. · Firm: BRIDGEBIO PHARMA, INC.
Give Kids a Chance Act of 2025 - H.R. 1262; S 932 Camerons Law - H.R. 1414 Tax Provisions in H.R. 1 - One Big Beautiful Bill Act - R&D tax credit, bonus depreciation, interest deduction, Provisions related to PBM Reform in H.R. 1 - One Big Beautiful Bill Act ORPHAN Cures Act - included in H.R. 1 - One Big Beautiful Bill Act Orphan drug policies Scientific EXPERT Act of 2025 - H.R. 1532; S. 822
Mikaela Naylon Give Kids a Chance Act
Client: BRIDGEBIO PHARMA, INC. · Firm: BRIDGEBIO PHARMA, INC.
Give Kids a Chance Act of 2025 - H.R. 1262; S 932 General issues and provisions related to PBM Reform ORPHAN Cures Act - included in H.R. 1 - One Big Beautiful Bill Act Orphan drug policies
Mikaela Naylon Give Kids a Chance Act
Client: BRIDGEBIO PHARMA, INC. · Firm: BRIDGEBIO PHARMA, INC.
Give Kids a Chance Act of 2025 - H.R. 1262; S. 932 Orphan drug policies Scientific EXPERT Act of 2024 - H.R.1532; S. 822 Cameron's Law - H.R. 1414 FY25 Full Year Continuing Appropriations and Extensions Act - H.R. 1968
Mikaela Naylon Give Kids a Chance Act
Client: BRIDGEBIO PHARMA, INC. · Firm: BRIDGEBIO PHARMA, INC.
Give Kids a Chance Act of 2025 - H.R. 1262; S 932 General issues and provisions related to PBM Reform ORPHAN Cures Act - included in H.R. 1 - One Big Beautiful Bill Act Orphan drug policies
Mikaela Naylon Give Kids a Chance Act
Client: BRIDGEBIO PHARMA, INC. · Firm: BRIDGEBIO PHARMA, INC.
Give Kids a Chance Act of 2025 - H.R. 1262; S 932 Camerons Law - H.R. 1414 Tax Provisions in H.R. 1 - One Big Beautiful Bill Act - R&D tax credit, bonus depreciation, interest deduction, Provisions related to PBM Reform in H.R. 1 - One Big Beautiful Bill Act ORPHAN Cures Act - included in H.R. 1 - One Big Beautiful Bill Act Orphan drug policies Scientific EXPERT Act of 2025 - H.R. 1532; S. 822
Give Kids a Chance Act of 2025 - H.R. 1262; S. 932 Orphan drug policies Scientific EXPERT Act of 2024 - H.R.1532; S. 822 Cameron's Law - H.R. 1414 FY25 Full Year Continuing Appropriations and Extensions Act - H.R. 1968
Give Kids a Chance Act of 2025 - H.R. 1262; S 932 Camerons Law - H.R. 1414 Tax Provisions in H.R. 1 - One Big Beautiful Bill Act - R&D tax credit, bonus depreciation, interest deduction, Provisions related to PBM Reform in H.R. 1 - One Big Beautiful Bill Act ORPHAN Cures Act - included in H.R. 1 - One Big Beautiful Bill Act Orphan drug policies Scientific EXPERT Act of 2025 - H.R. 1532; S. 822
Give Kids a Chance Act of 2025 - H.R. 1262; S 932 Camerons Law - H.R. 1414 Tax Provisions in H.R. 1 - One Big Beautiful Bill Act - R&D tax credit, bonus depreciation, interest deduction, Provisions related to PBM Reform in H.R. 1 - One Big Beautiful Bill Act ORPHAN Cures Act - included in H.R. 1 - One Big Beautiful Bill Act Orphan drug policies Scientific EXPERT Act of 2025 - H.R. 1532; S. 822
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: BRIDGEBIO PHARMA, INC. · Firm: BRIDGEBIO PHARMA, INC.
Give Kids a Chance Act of 2025 - H.R. 1262; S. 932 Orphan drug policies Scientific EXPERT Act of 2024 - H.R.1532; S. 822 Cameron's Law - H.R. 1414 FY25 Full Year Continuing Appropriations and Extensions Act - H.R. 1968
Give Kids a Chance Act of 2025 - H.R. 1262; S. 932 Orphan drug policies Scientific EXPERT Act of 2024 - H.R.1532; S. 822 Cameron's Law - H.R. 1414 FY25 Full Year Continuing Appropriations and Extensions Act - H.R. 1968
Give Kids a Chance Act of 2025 - H.R. 1262; S 932 Camerons Law - H.R. 1414 Tax Provisions in H.R. 1 - One Big Beautiful Bill Act - R&D tax credit, bonus depreciation, interest deduction, Provisions related to PBM Reform in H.R. 1 - One Big Beautiful Bill Act ORPHAN Cures Act - included in H.R. 1 - One Big Beautiful Bill Act Orphan drug policies Scientific EXPERT Act of 2025 - H.R. 1532; S. 822
Give Kids a Chance Act of 2025 - H.R. 1262; S 932 General issues and provisions related to PBM Reform ORPHAN Cures Act - included in H.R. 1 - One Big Beautiful Bill Act Orphan drug policies
Give Kids a Chance Act of 2025 - H.R. 1262; S 932 Camerons Law - H.R. 1414 Tax Provisions in H.R. 1 - One Big Beautiful Bill Act - R&D tax credit, bonus depreciation, interest deduction, Provisions related to PBM Reform in H.R. 1 - One Big Beautiful Bill Act ORPHAN Cures Act - included in H.R. 1 - One Big Beautiful Bill Act Orphan drug policies Scientific EXPERT Act of 2025 - H.R. 1532; S. 822
Give Kids a Chance Act of 2025 - H.R. 1262; S 932 General issues and provisions related to PBM Reform ORPHAN Cures Act - included in H.R. 1 - One Big Beautiful Bill Act Orphan drug policies
To authorize any Indian Tribe to lease, sell, convey, warrant, or otherwise transfer real property to which that Indian Tribe holds fee title without the consent of the Federal Government, and for other purposes.
Client: BRIDGEBIO PHARMA, INC. · Firm: BRIDGEBIO PHARMA, INC.
Give Kids a Chance Act of 2025 - H.R. 1262; S. 932 Orphan drug policies Scientific EXPERT Act of 2024 - H.R.1532; S. 822 Cameron's Law - H.R. 1414 FY25 Full Year Continuing Appropriations and Extensions Act - H.R. 1968
Give Kids a Chance Act of 2025 - H.R. 1262; S. 932 Orphan drug policies Scientific EXPERT Act of 2024 - H.R.1532; S. 822 Cameron's Law - H.R. 1414 FY25 Full Year Continuing Appropriations and Extensions Act - H.R. 1968
Creating Hope Reauthorization Act of 2024 - H.R. 7384 Give Kids a Chance Act of 2024 - H.R. 3433 Creating Hope Reauthorization Act of 2024 - S. 4583 March-in/Bayh-Dole Act Orphan drug policies Scientific EXPERT Act of 2024 - H.R.9979 H.R.9979 - Scientific EXPERT Act of 2024 H.R.10545 - American Relief Act, 2025
Give Kids a Chance Act of 2024
Client: BRIDGEBIO PHARMA, INC. · Firm: BRIDGEBIO PHARMA, INC.
Creating Hope Reauthorization Act of 2024 - H.R. 7384 Give Kids a Chance Act of 2024 - H.R. 3433 Creating Hope Reauthorization Act of 2024 - S. 4583 March-in/Bayh-Dole Act Orphan drug policies
Give Kids a Chance Act of 2024
Client: BRIDGEBIO PHARMA, INC. · Firm: BRIDGEBIO PHARMA, INC.
Creating Hope Reauthorization Act of 2024 - H.R. 7384 Give Kids a Chance Act of 2024 - H.R. 3433 Creating Hope Reauthorization Act of 2024 - S. 4583 March-in/Bayh-Dole Act Orphan drug policies Scientific EXPERT Act of 2024 - H.R.9979 H.R.9979 - Scientific EXPERT Act of 2024 H.R.10545 - American Relief Act, 2025
Innovation in Pediatric Drugs Act of 2023
Client: BRIDGEBIO PHARMA, INC. · Firm: BRIDGEBIO PHARMA, INC.
Creating Hope Reauthorization Act of 2024 - H.R. 7384 Innovation in Pediatric Drugs Act - H.R. 6664 March-in/Bayh-Dole Act Orphan drug policies
Innovation in Pediatric Drugs Act of 2023
Client: BRIDGEBIO PHARMA, INC. · Firm: BRIDGEBIO PHARMA, INC.
Creating Hope Reauthorization Act of 2024 - H.R. 7384 Innovation in Pediatric Drugs Act - H.R. 6664 March-in/Bayh-Dole Act Orphan drug policies
Creating Hope Reauthorization Act of 2024
Client: BRIDGEBIO PHARMA, INC. · Firm: BRIDGEBIO PHARMA, INC.
Creating Hope Reauthorization Act of 2024 - H.R. 7384 Innovation in Pediatric Drugs Act - H.R. 6664 March-in/Bayh-Dole Act Orphan drug policies
Creating Hope Reauthorization Act of 2024
Client: BRIDGEBIO PHARMA, INC. · Firm: BRIDGEBIO PHARMA, INC.
Creating Hope Reauthorization Act of 2024 - H.R. 7384 Innovation in Pediatric Drugs Act - H.R. 6664 March-in/Bayh-Dole Act Orphan drug policies
Creating Hope Reauthorization Act of 2024
Client: BRIDGEBIO PHARMA, INC. · Firm: BRIDGEBIO PHARMA, INC.
Creating Hope Reauthorization Act of 2024 - H.R. 7384 Give Kids a Chance Act of 2024 - H.R. 3433 Creating Hope Reauthorization Act of 2024 - S. 4583 March-in/Bayh-Dole Act Orphan drug policies
Creating Hope Reauthorization Act of 2024
Client: BRIDGEBIO PHARMA, INC. · Firm: BRIDGEBIO PHARMA, INC.
Creating Hope Reauthorization Act of 2024 - H.R. 7384 Give Kids a Chance Act of 2024 - H.R. 3433 Creating Hope Reauthorization Act of 2024 - S. 4583 March-in/Bayh-Dole Act Orphan drug policies Scientific EXPERT Act of 2024 - H.R.9979 H.R.9979 - Scientific EXPERT Act of 2024 H.R.10545 - American Relief Act, 2025
Creating Hope Reauthorization Act of 2024 - H.R. 7384 Give Kids a Chance Act of 2024 - H.R. 3433 Creating Hope Reauthorization Act of 2024 - S. 4583 March-in/Bayh-Dole Act Orphan drug policies Scientific EXPERT Act of 2024 - H.R.9979 H.R.9979 - Scientific EXPERT Act of 2024 H.R.10545 - American Relief Act, 2025
Creating Hope Reauthorization Act of 2024
Client: BRIDGEBIO PHARMA, INC. · Firm: BRIDGEBIO PHARMA, INC.
Creating Hope Reauthorization Act of 2024 - H.R. 7384 Give Kids a Chance Act of 2024 - H.R. 3433 Creating Hope Reauthorization Act of 2024 - S. 4583 March-in/Bayh-Dole Act Orphan drug policies
Creating Hope Reauthorization Act of 2024
Client: BRIDGEBIO PHARMA, INC. · Firm: BRIDGEBIO PHARMA, INC.
Creating Hope Reauthorization Act of 2024 - H.R. 7384 Give Kids a Chance Act of 2024 - H.R. 3433 Creating Hope Reauthorization Act of 2024 - S. 4583 March-in/Bayh-Dole Act Orphan drug policies Scientific EXPERT Act of 2024 - H.R.9979 H.R.9979 - Scientific EXPERT Act of 2024 H.R.10545 - American Relief Act, 2025
ORPHAN Cures Act H.R. 5539; S. 3131 Promising Pathways Act HR 4408; S. 1906 PAHPA H.R.469 PAHPA S.R. 2333 Innovation in Pediatric Drugs Act of 2023
ORPHAN Cures Act H.R. 5539; S. 3131 Promising Pathways Act HR 4408; S. 1906 PAHPA H.R.469 PAHPA S.R. 2333 Innovation in Pediatric Drugs Act of 2023
ORPHAN Cures Act H.R. 5539; S. 3131 Promising Pathways Act HR 4408; S. 1906 PAHPA H.R.469 PAHPA S.R. 2333 Innovation in Pediatric Drugs Act of 2023
ORPHAN Cures Act H.R. 5539; S. 3131 Promising Pathways Act HR 4408; S. 1906 PAHPA H.R.469 PAHPA S.R. 2333 Innovation in Pediatric Drugs Act of 2023
ORPHAN Cures Act H.R. 5539; S. 3131 Promising Pathways Act HR 4408; S. 1906 PAHPA H.R.469 PAHPA S.R. 2333 Innovation in Pediatric Drugs Act of 2023
Orphan drug policies General issues and provisions related to PBM Reform General issues and provisions related to tariffs H.R.1532 and S.822 - Scientific EXPERT Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIDGEBIO PHARMA, INC. via BRIDGEBIO PHARMA, INC.
2026 · first_quarter · Q1
H.R.7148 - Consolidated Appropriations Act, 2026 Give Kids a Chance Act of 2025 - H.R. 1262; S 932 Orphan drug policies General issues and provisions related to PBM Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIDGEBIO PHARMA, INC. via BRIDGEBIO PHARMA, INC.
2025 · fourth_quarter · 4A
Give Kids a Chance Act of 2025 - H.R. 1262; S 932 General issues and provisions related to PBM Reform ORPHAN Cures Act - included in H.R. 1 - One Big Beautiful Bill Act Orphan drug policies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIDGEBIO PHARMA, INC. via BRIDGEBIO PHARMA, INC.
2025 · fourth_quarter · Q4
Give Kids a Chance Act of 2025 - H.R. 1262; S 932 General issues and provisions related to PBM Reform ORPHAN Cures Act - included in H.R. 1 - One Big Beautiful Bill Act Orphan drug policies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIDGEBIO PHARMA, INC. via BRIDGEBIO PHARMA, INC.
2025 · second_quarter · Q2
Give Kids a Chance Act of 2025 - H.R. 1262; S 932 Camerons Law - H.R. 1414 Tax Provisions in H.R. 1 - One Big Beautiful Bill Act - R&D tax credit, bonus depreciation, interest deduction, Provisions related to PBM Reform in H.R. 1 - One Big Beautiful Bill Act ORPHAN Cures Act - included in H.R. 1 - One Big Beautiful Bill Act Orphan drug policies Scientific EXPERT Act of 2025 - H.R. 1532; S. 822
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIDGEBIO PHARMA, INC. via BRIDGEBIO PHARMA, INC.
2025 · first_quarter · Q1
Give Kids a Chance Act of 2025 - H.R. 1262; S. 932 Orphan drug policies Scientific EXPERT Act of 2024 - H.R.1532; S. 822 Cameron's Law - H.R. 1414 FY25 Full Year Continuing Appropriations and Extensions Act - H.R. 1968
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIDGEBIO PHARMA, INC. via BRIDGEBIO PHARMA, INC.
2024 · fourth_quarter · Q4
Creating Hope Reauthorization Act of 2024 - H.R. 7384 Give Kids a Chance Act of 2024 - H.R. 3433 Creating Hope Reauthorization Act of 2024 - S. 4583 March-in/Bayh-Dole Act Orphan drug policies Scientific EXPERT Act of 2024 - H.R.9979 H.R.9979 - Scientific EXPERT Act of 2024 H.R.10545 - American Relief Act, 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIDGEBIO PHARMA, INC. via BRIDGEBIO PHARMA, INC.
2024 · third_quarter · Q3
Creating Hope Reauthorization Act of 2024 - H.R. 7384 Give Kids a Chance Act of 2024 - H.R. 3433 Creating Hope Reauthorization Act of 2024 - S. 4583 March-in/Bayh-Dole Act Orphan drug policies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIDGEBIO PHARMA, INC. via BRIDGEBIO PHARMA, INC.
2024 · second_quarter · Q2
Creating Hope Reauthorization Act of 2024 - H.R. 7384 Innovation in Pediatric Drugs Act - H.R. 6664 March-in/Bayh-Dole Act Orphan drug policies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIDGEBIO PHARMA, INC. via BRIDGEBIO PHARMA, INC.
2024 · first_quarter · Q1
Creating Hope Reauthorization Act of 2024 - H.R. 7384 Innovation in Pediatric Drugs Act - H.R. 6664 March-in/Bayh-Dole Act Orphan drug policies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIDGEBIO PHARMA, INC. via BRIDGEBIO PHARMA, INC.
2023 · fourth_quarter · Q4
ORPHAN Cures Act H.R. 5539; S. 3131 Promising Pathways Act HR 4408; S. 1906 PAHPA H.R.469 PAHPA S.R. 2333 Innovation in Pediatric Drugs Act of 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIDGEBIO PHARMA, INC. via BRIDGEBIO PHARMA, INC.
2023 · fourth_quarter · RR
Orphan drug policies; FDA policy